Ocular Therapeutix (OCUL) Interest Coverage Ratio Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.78% |
| Dec 31, 2025 | -24.27% |
| Sep 30, 2025 | -22.88% |
| Jun 30, 2025 | -16.26% |
| Mar 31, 2025 | -16.06% |
| Dec 31, 2024 | -6.55% |
| Sep 30, 2024 | -0.35% |
| Jun 30, 2024 | -0.54% |
| Mar 31, 2024 | 16.57% |
| Dec 31, 2023 | 36.34% |
| Sep 30, 2023 | 30.64% |
| Jun 30, 2023 | 19.10% |
| Mar 31, 2023 | 14.36% |
| Dec 31, 2022 | 16.58% |
| Sep 30, 2022 | 17.28% |
| Jun 30, 2022 | 21.42% |
| Mar 31, 2022 | 21.43% |
| Dec 31, 2021 | 18.48% |
| Sep 30, 2021 | 11.49% |
| Jun 30, 2021 | 14.38% |
| Mar 31, 2021 | 13.68% |
| Dec 31, 2020 | 19.89% |
| Sep 30, 2020 | 21.57% |
| Jun 30, 2020 | 15.00% |
| Mar 31, 2020 | 6.30% |
| Dec 31, 2019 | 8.56% |
| Sep 30, 2019 | 3.14% |
| Jun 30, 2019 | 10.51% |
| Mar 31, 2019 | 34.38% |
| Dec 31, 2018 | -4.23% |
| Sep 30, 2018 | 0.89% |
| Jun 30, 2018 | -1.31% |